Watanabe N, Niitsu Y
Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 2):1322-8.
TNF is cytokine derived from macrophages and holds strong promise for application to cancer therapy because of its marked antitumor effects and its high specificity to tumors. The clinical application (Phase I-II) of TNF has been started because human recombinant TNF (rH-TNF) can been produced on a large scale. In spite of notable antitumor effects, little is known concerning the mechanism of action of its cytotoxic activity. In this article, the antitumor effects of rH-TNF against human and murine tumors, the mechanism of its action and the synergistic effects of rH-TNF in combination with IFN-gamma or with cyclophosphamide are reviewed.
肿瘤坏死因子(TNF)是一种源自巨噬细胞的细胞因子,因其显著的抗肿瘤作用以及对肿瘤的高度特异性,在癌症治疗应用方面极具前景。由于能够大规模生产重组人肿瘤坏死因子(rH-TNF),TNF的临床应用(I-II期)已经启动。尽管TNF具有显著的抗肿瘤作用,但其细胞毒性活性的作用机制却鲜为人知。本文综述了rH-TNF对人和鼠类肿瘤的抗肿瘤作用、其作用机制以及rH-TNF与γ干扰素或环磷酰胺联合使用时的协同效应。